Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
about
Expanding the antimalarial toolkit: Targeting host-parasite interactionsMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsSelection and refinement: the malaria parasite's infection and exploitation of host hepatocytesMalaria Parasites: The Great EscapeImplications of Plasmodium vivax Biology for Control, Elimination, and ResearchNew developments in anti-malarial target candidate and product profilesNeglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationMalaria Parasite Liver Infection and Exoerythrocytic Biology.Improvement of culture conditions for long-term in vitro culture of Plasmodium vivax.Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice.LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage.Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.Key Knowledge Gaps for Plasmodium vivax Control and EliminationTowards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers.Experimental systems for studying Plasmodium/HIV coinfection.An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Drug target identification in protozoan parasites.Phenotypic Screens in Antimalarial Drug Discovery.Susceptibility Testing of Medically Important Parasites.Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.The Biology of Plasmodium vivax.Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.Infection of laboratory colonies of Anopheles mosquitoes with Plasmodium vivax from cryopreserved clinical isolates.IFN-γ protects hepatocytes against Plasmodium vivax infection via LAP-like degradation of sporozoites.Hepatitis E virus: advances and challenges.Humanized mouse models infected with human Plasmodium species for antimalarial drug discovery.Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles.malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.Engineered Livers for Infectious Diseases.A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite Plasmodium cynomolgi.Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan.Nuclear, Cytosolic, and Surface-Localized Poly(A)-Binding Proteins of Plasmodium yoelii.Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia.A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.Molecular evidence for relapse of an imported Plasmodium ovale wallikeri infection.Plasmodium vivax Biology: Insights Provided by Genomics, Transcriptomics and Proteomics.
P2860
Q26772866-AA8F0C11-3E2B-469E-B5D3-12634890876EQ26781372-A5E4CEA4-DE20-4352-B05E-F10AF4F93BEDQ27025899-DE2BF124-B951-4B59-8D5B-5028C03F702DQ28080325-4161C6C3-ACD0-4916-885F-3301E4DB6F88Q28355362-5558C4A3-0283-4388-B130-D5DDCB217099Q28468598-D4DD96B2-2D8A-4AF3-9D8D-BBD00D7627D5Q28602660-97EB14F6-62FA-4003-B807-0D1439C80D3FQ34552223-49D619FF-F0B9-4340-A74E-FF53C1B8A51AQ35914904-6A91DD6D-0049-41E8-B0CB-805E236AA42BQ35917180-CAE21209-647F-41C2-9C96-01BDB921F33AQ37040642-95D26527-29E7-4755-BA02-026E3134B907Q37515070-4F940A25-6041-42E6-BAE0-235DC705EB64Q37546198-CD628055-3ED4-482A-8AFC-E480D6D96A88Q37731353-1799C8A3-516C-42EA-BFD7-42164CA5FCB5Q38786988-822AF0D4-3935-4D85-BE0A-1920093B1699Q38794455-80F580C3-D331-4DF9-BA4D-702D5C1B3239Q38847814-764F323F-8F1B-462E-A7AB-A574F8F60CA8Q38849773-7015B95D-10CD-4612-9C87-158D05940801Q39020376-1E48DA1A-3E82-4F10-9BEF-413959175085Q39587294-6CF04477-5909-41DA-8A9D-3F7A97A09AABQ40218474-45EC740C-9E0E-447D-BE2F-F3D9EE61C245Q40376176-D122DBBA-1FDD-4E17-AAD3-43393EA04455Q40398599-BD1ECB09-E112-4F5A-B4FF-9DD9D9464B73Q40600483-C56520BA-0A76-4D17-8AAE-41BA6CB2CFB4Q42533696-D3EF7927-EF99-4DFB-B8B5-E0D961C47992Q45324469-26F5FF68-3C3F-4840-8591-F95A76696C2AQ46252657-A95E0A04-8BDA-40A1-8811-8348B2B0E6BFQ47099112-3C83FE42-BB6D-49E0-B9D9-9593A7DEB2A1Q47134819-1D10E54F-98BC-4ED1-BC8C-085DF18F0ABBQ47150499-1B2118E3-142E-48E6-B1D9-851C664BCF0AQ47162062-11876F68-CA77-4514-8AA0-DC430F31BC99Q47555660-27D6539A-E476-44EC-B4DE-CFBEB307CBBAQ48018710-9196E021-3270-478E-98FD-90449C2D6895Q48021575-6FA849CF-8FA2-42EC-B3C8-073270DC7390Q48022526-24800CA8-0177-406A-A3AE-F37619A2AE91Q48022885-B6391B52-B826-41A9-B596-6D2D3DB82D99Q48023011-F7731476-2276-478F-ADFD-82E3457385B0Q48023325-302C21E1-B224-486D-A80B-0E0BEAC44E3DQ50094127-9A9E1222-5873-4471-8F8D-7CB4B40E95BAQ50225360-30DEE1CC-6986-4234-9DB6-789DAF54ACED
P2860
Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@en
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@nl
type
label
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@en
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@nl
prefLabel
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@en
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@nl
P2093
P2860
P50
P1433
P1476
Plasmodium vivax liver stage d ...... in human liver-chimeric mice.
@en
P2093
Alexis Kaushansky
Matthew Fishbaugher
Michael Baldwin
Narathatai Yimamnuaychok
Naresh Singh
Nastaran Rezakhani
Nelly Camargo
Niwat Kangwanrangsan
Scott E Lindner
Viswanathan Lakshmanan
P2860
P304
P356
10.1016/J.CHOM.2015.02.011
P577
2015-03-19T00:00:00Z